Incyte tops this list due to its rare combination of commercial scale, cash generation, and pipeline depth. The company posted FY2025 revenue of $5.14 billion, up 21.2% YoY, anchored by Jakafi generating $828.2 million in Q4 2025 alone (+7% YoY) and Opzelura delivering $207.3 million (+28% YoY). With $3.58 billion in cash and 14 pivotal clinical trials underway, Incyte offers an acquirer immediate revenue, margin expansion potential, and a deep oncology pipeline spanning KRASG12D, CDK2 inhibition, and mutCALR.
A report last year found unnecessary surgeries were carried out, cancers were missed and poor standards of care were delivered at the University Hospital of North Durham and Darlington Memorial Hospital. CDDTF said it wanted to support the patients it had let down, including by offering access to psychological support, and to ensure they knew how to make a claim or raise concerns with police.
Some 1 million patients in the U.S. live with a type of heart disease called heart failure with preserved ejection fraction, or HFpEF, caused by a stiffening of a chamber of the heart that makes it much more challenging to distribute blood throughout the body. The condition has few approved therapies and high mortality rates.
Public health consultant Dr Ross Keat said supporting people earlier to make small preventative changes would make "a big difference later on". Some 3,500 people in the north of the island within that age bracket are eligible for the checks. The checks will be carried out by two pre-existing nurses that support GP staff and would not replace GP appointments, Keat explained, adding that the cost would be minimal and absorbed by Ramsey Group Practice.
Jessica Mason went back and forth to her GP and hospital with swelling, bleeding and pain in her vagina but says she was "fobbed off" before "begging" for a scan which revealed cancer requiring urgent treatment. The 44-year-old believes she was only referred for an MRI because she "broke down in tears" to a doctor, adding: "I knew there was something wrong."
You get sick from staying inside, breathing the same germ-filled air. Open your windows, even for five minutes, to circulate the old air out and let in fresh air. Also, if you're taking your child to the doctor, don't wait to treat their fever because you want 'the provider to see the fever.' Your child might wait two hours to be seen, meanwhile their temperature goes up, and they might have a seizure. If you say they've been having fevers, we believe you.
After losing both of his parents to cancer, Tom set out to challenge a healthcare system that often waits for symptoms instead of identifying risk early. What began in Deerfield Beach, Florida, has grown into a multi-location preventative imaging company serving communities across the state. Life Imaging Fla focuses on preventative heart and full-body screenings. These services give people access to advanced imaging that is typically only approved once symptoms appear. The goal is straightforward: identify disease earlier, when people still have time, options, and control.
Eduardo Vilar-Sanchez has spent more than 10 years pursuing a goal that seemed very distant, but which he now sees as a little closer: to develop a preventive vaccine against cancer. The physician and researcher is leading a study that presented the first promising results of a colon cancer vaccine in a small group of patients suffering from a rare disease that makes them 17 times more likely to develop colon cancer than the general population.
AI plays an important role-but not by fixing fragmented data on its own. The work of organizing, connecting, and interpreting healthcare information still belongs to people and the systems they build. Where AI helps is after that foundation is in place: by bringing the right information forward at the right time, reducing the effort it takes to find what matters, and supporting better decisions in the moment of care.
He has been living with atrial fibrillation (AF), a common heart rhythm problem, affecting 1.4m people in the UK, that can cause your heart to beat irregularly and often too fast. "It's very debilitating. On my worst day I feel very tired, my heart rate increases rapidly - I could walk for 2 or 3 miles and be okay, I could walk for 100 yards and it would hit me."
But questions remain about the accuracy and uncertainty of these tests, and experts caution that the assays aren't ready for prime time. While the results here are encouraging, they are not yet at the level of having significant clinical benefit for individual patients, says Corey Bolton, a clinical neuropsychologist and an assistant professor of medicine at Vanderbilt University Medical Center, who was not involved in the new study.
